Envestnet Asset Management Inc. lifted its stake in shares of LeMaitre Vascular Inc (NASDAQ:LMAT) by 15.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. T
Sidoti analyst James Sidoti upgraded Lemaitre Vascular (LMAT) to Buy today and set a price target of $38.00. The company's shares closed last Monday at
Sidoti analyst James Sidoti upgraded Lemaitre Vascular ( LMAT – Research Report ) to Buy today and set a price target of $38.00 . The company’s shares closed last Monday at $24.45. According to Ti
Charles Schwab Investment Management Inc. increased its position in LeMaitre Vascular Inc (NASDAQ:LMAT) by 3.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exch
T2 Biosystems (NASDAQ:TTOO) and LeMaitre Vascular (NASDAQ:LMAT) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of th
A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which declared increased dividends. Companies with upcoming ex-dividend d
Interpace Diagnostics Group (NASDAQ:IDXG) and LeMaitre Vascular (NASDAQ:LMAT) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the s
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo...

Stocks That Hit 52-Week Lows On Thursday

04:10pm, Thursday, 12'th Mar 2020
Barclays PLC lifted its holdings in LeMaitre Vascular Inc (NASDAQ:LMAT) by 31.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). T
KBC Group NV purchased a new stake in LeMaitre Vascular Inc (NASDAQ:LMAT) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 10,572
Capital Impact Advisors LLC boosted its position in shares of LeMaitre Vascular Inc (NASDAQ:LMAT) by 5.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exc
In 1992 George LeMaitre was appointed CEO of LeMaitre Vascular, Inc. (NASDAQ:LMAT). This analysis aims first to...
New York State Common Retirement Fund lowered its stake in shares of LeMaitre Vascular Inc (NASDAQ:LMAT) by 16.4% during the 4th quarter, according to the company in its most recent Form 13F filing wi
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE